This year’s ATOMEXPO International Forum in Sochi will feature a roundtable discussion on “Nuclear Medicine: Trends, Innovations and Best Practices” organized by Rusatom Healthcare (a medical integrator that is part of the ROSATOM) in conjunction with the official supplier of isotope products to Rosatom, JSC Isotope.
The roundtable will bring together experts from Russia and around the world to discuss the contribution of nuclear medicine and medical radiology to sustainable development. The speakers will address the most pressing issues in the industry, including trends in molecular visualization, the future of radiation therapy and promising areas of radionuclide diagnostics. They will also pay attention to the regional features of nuclear medicine, with Dr. Emerson Soares Bernardes scheduled to present an overview of nuclear medicine in Latin America and the General Manager of Turkey’s Eczacıbaşı-Monrol Aydin Kucuk set to talk about his experience in the development of nuclear medicine in the country.
The roundtable will be attended by representatives of the following companies: the Radiopharmacy Center at the Nuclear and Energy Research Institute (Brazil); GE Healthcare (United States); Elekta (Sweden); radiopharmaceutical manufacturer Eczacıbaşı-Monrol (Turkey); and Burnasyan Federal Medical Biophysical Center of the Federal-Medical Biological Agency (Russia). General Director of Rusatom Healthcare Aleksandr Shibanov will deliver the opening address at the roundtable. The event will be moderated by Morris Hossein, Senior Partner at Pharma & Healthcare, part of the Roland Berger international consulting firm.
The roundtable will take place from 10:00 to 12:00 on 16 April in the Green Hall of the Main Media Centre.
For reference:
Nuclear medicine is one of the most dynamically developing fields of healthcare in the world today. Modern methods of nuclear medicine used in diagnostics and treatment have allowed us to move to a qualitatively new level in the fight against cancer and other diseases as a result of its high efficacy and, in a number of cases, the lack of alternatives.
The main topic for this year’s Forum is “Nuclear for better life.” For the first time in the history of the Forum, the business programme has been compiled by the International Programme Committee, which is made up of: Director General of the OECD Nuclear Energy Agency William Magwood, Director General of the World Nuclear Association (WNA) Agneta Rising, former Chairman of the World Association of Nuclear Operators Jacques Régaldo and former Director-General of the OECD Nuclear Energy Agency Luis E. Echávarri, among others. ATOMEXPO 2019 participants (heads of state structures, major companies and public organizations, as well as international experts) will discuss global issues in the development of carbon-free energy, a responsible approach to the environment and natural resources, green investments and international partnerships for sustainable development. Among the key topics at roundtables are: the non-energy application of nuclear and radiation technologies in industry, science, medicine and agriculture; digital solutions for infrastructure projects; knowledge management; and the development of human capital assets. A number of important documents are expected to be signed on the side-lines of the Forum, including agreements on strategic cooperation and partnership, commercial contracts and documents on the development of projects. The exhibition will feature a wide range of advanced nuclear technologies and new products, including products that are not related to the energy industry. The exhibition area will take up over 13,000 square metres.
The 10th anniversary ATOMEXPO Forum in 2018 attracted over 4000 delegates and guests from 68 countries (compared to 65 countries in 2017 and 55 countries in 2016). The exhibition took place on a total area of 20,000 square metres (compared to 12,000 square metres in 2017). Over 600 companies took part in the event. A total of 39 agreements and other documents on cooperation and partnership, including commercial contracts, were signed on the side-lines of ATOMEXPO 2018.
